Dr. Wassim W. Labaki

Dr. Labaki is an Assistant Professor in the Division of Pulmonary and Critical Care Medicine and the Medical Director of the Lung Volume Reduction Program at the University of Michigan. He earned his medical degree from Georgetown University, and completed his residency in Internal Medicine at the Johns Hopkins Hospital and his fellowship in Pulmonary and Critical Care Medicine at the University of Michigan. He also earned a Master’s Degree in Clinical Research Design and Statistical Analysis from the University of Michigan School of Public Health.Dr. Labaki is a provider in the multidisciplinary COPD Clinic and a member of the COPD Quality Improvement Committee at the University of Michigan. He conducts clinical and translational research in COPD, including its epidemiology, natural history, chest imaging biomarkers, and more recently metabolomics. He is also involved in the institutional operations of several NIH-sponsored COPD studies and clinical trials. In 2019, Dr. Labaki was the recipient of the Sreedhar Nair Early Stage Investigator Award in COPD from the American Thoracic Society. He sits on the Editorial Board of the Journal of the COPD Foundation and is an active member of the American Thoracic Society, European Respiratory Society and the Metabolomics Association of North America.

Dr. Labaki is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Chronic Obstructive Pulmonary Disease (COPD), Emphysema, Lung Metastases, Cystic Fibrosis, and Endoscopy.

Dr. Labaki is board certified in Pulmonary Disease and Critical Care Medicine. He is actively involved in clinical research, co-authoring 91 peer reviewed articles.